Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

In China, Massive Police Sweep For Fake Drugs

China’s public security ministry announced over the weekend that police had detained nearly 2,000 individuals in a sweeping late-July raid on manufacturers of counterfeit drugs.

Fake drug stockpiles worth more than $180 million were seized, including impostor meds for the treatment of diabetes, high blood pressure, and even cancer.

According to the ministry’s report, the counterfeit drugs likely contained toxic substances and are suspected to have caused consumers to suffer liver and kidney damage.

More than 18,000 police were involved in the recent crackdown, which authorities say resulted in the destruction of more than 1,100 counterfeit-drug-making facilities.

We’ll have much more on this story in this week’s China Compliance Digest: Rx Edition.

A two-issue free trial subscription is available at the CCD: Rx website.

______________

Ben Kessler is a contributing editor of the FCPA Blog and the editor of the China Compliance Digest and the China Compliance Digest: Rx Edition.

Share this post

LinkedIn
Facebook
Twitter

Comments are closed for this article!